Elsevier

Journal of Cardiac Failure

Volume 5, Issue 4, December 1999, Pages 357-382
Journal of Cardiac Failure

Heart failure society of America (HFSA) practice guidelines
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches

https://doi.org/10.1016/S1071-9164(99)91340-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (130)

  • M Gheorghiade et al.

    Digitalis investigation group (DIG) trial: a stimulus for further research

    Am Heart J

    (1997)
  • H Krum et al.

    Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

    J Am Coll Cardiol

    (1995)
  • KF Adams et al.

    Patients with mild heart failure worsen during withdrawal from digoxin therapy

    J Am Coll Cardiol

    (1997)
  • GE Newton et al.

    Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

    J Am Coll Cardiol

    (1996)
  • ML Slatton et al.

    Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

    J Am Coll Cardiol

    (1997)
  • BJ Zarowitz et al.

    Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing?

    Am Heart J

    (1992)
  • E Sbarouni et al.

    Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure

    Am Heart J

    (1994)
  • K Yamamoto et al.

    The coagulation system is activated in idiopathic cardiomyopathy

    J Am Coll Cardiol

    (1995)
  • A Laupacis et al.

    Antithrombotic therapy in atrial fibrillation

    Chest

    (1998)
  • PD Natterson et al.

    Risk of arterial embolization in 224 patients awaiting cardiac transplantation

    Am Heart J

    (1995)
  • DL Dries et al.

    Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials

    J Am Coll Cardiol

    (1997)
  • AS Al-Khadra et al.

    Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction

    J Am Coll Cardiol

    (1998)
  • AS Al-Khadra et al.

    Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial

    J Am Coll Cardiol

    (1998)
  • KN Nguyen et al.

    Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Am J Cardiol

    (1997)
  • J Leor et al.

    Aspirin and mortality in patients treated with angiotensin-converting enzyme

    J Am Coll Cardiol

    (1999)
  • D Hall et al.

    Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

    J Am Coll Cardiol

    (1992)
  • M Oosterga et al.

    Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction

    Am J Cardiol

    (1998)
  • B Pitt et al.

    Overview of angiotensin II receptor antagonists

    Am J Cardiol

    (1998)
  • K Dickstein et al.

    Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe heart failure

    J Am Coll Cardiol

    (1995)
  • B Pitt et al.

    Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of the patients in the Losartan Heart Failure Survival Study (ELITE II)

    J Card Fail

    (1999)
  • GC Flaker et al.

    Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation

    J Am Coll Cardiol

    (1992)
  • AL Waldo et al.

    Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

    Lancet

    (1996)
  • HC Doval et al.

    Randomized trial of low-dose amiodarone in severe congestive heart failure

    Lancet

    (1994)
  • American Heart Association

    1998 Heart and Stroke Statistical Update

  • KKL Ho et al.

    The epidemiology of heart failure: the Framingham Study

    J Am Coll Cardiol

    (1993)
  • H Eriksson

    Heart failure: a growing public health problem

    J Intern Med

    (1995)
  • JK Ghali et al.

    Trends in hospitalization rates for heart failure in the United States, 1973–1986: evidence for increasing population prevalence

    Arch Intern Med

    (1990)
  • EJ Graves

    National hospital discharge survey: annual summary, 1993

  • Centers for Disease Control and Prevention

    Cerebrovascular disease mortality and Medicare hospitalization-United States, 1980–1990

    MMWR

    (1992)
  • JB O'Connell et al.

    Economic impact of heart failure in the United States: time for a different approach

    J Heart Lung Transplant

    (1994)
  • M Packer

    How should physicians view heart failure?

  • JN Cohn

    Vasodilator therapy for heart failure: the influence of impedance on left ventricular performance

    Circulation

    (1973)
  • GS Francis et al.

    The neurohormonal axis in congestive heart failure

    Ann Intern Med

    (1984)
  • MA Pfeffer et al.

    Ventricular remodeling after myocardial infarction: experimental observations and clinical implications

    Circulation

    (1990)
  • JN Cohn

    Structural basis for heart failure: ventricular remodeling and its pharmacologic inhibition

    Circulation

    (1995)
  • EJ Eichhorn et al.

    Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure

    Circulation

    (1996)
  • M Gheorghiade et al.

    Chronic heart failure in the United States: a manifestation of coronary artery disease

    Circulation

    (1998)
  • MA Konstam et al.

    Heart failure: evaluation and care of patients with left ventricular systolic dysfunction

    (1994)
  • ACC/AHA Task Force on Practice Guidelines

    Guidelines for the evaluation and management of heart failure

    Circulation

    (1995)
  • Task Force of the Working Group for Heart Failure of the European Society of Cardiology

    The treatment of heart failure

    Eur Heart J

    (1997)
  • Cited by (328)

    • Global heart failure rates and erythropoietin

      2012, Journal of Medical Hypotheses and Ideas
    • Development and Implementation of Practice Guidelines in Heart Failure

      2010, Heart Failure: A Companion to Braunwald's Heart Disease Expert Consult
    View all citing articles on Scopus

    This document is available on the HFSA web site (www.hfsa.org).

    View full text